Home › Funds › Peloton Wealth Strategists › VRTX

Peloton Wealth Strategists position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Peloton Wealth Strategists reported holding 13,290 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 2.54% of its reported portfolio and ranking #11 among its reported holdings. Peloton Wealth Strategists has disclosed VRTX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)13.29K sh
Reported value held$6.95M
Portfolio Weight2.54%
First reportedQ2 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Peloton Wealth Strategists's VRTX position evolved

Peloton Wealth Strategists first disclosed a stake in VRTX in Q2 2024 at 575 shares (US$270K). The position peaked in Q3 2026 at 13,290 shares, worth US$6.9M. Across 10 filings, Peloton Wealth Strategists increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 13,290 shares valued at US$6.9M — an increase of 4,010 shares quarter over quarter.. Notable position changes include a 278% increase in Q3 2024 (shares fell 13% over the following quarter), a 177% increase in Q4 2024 (shares rose 20% over the following quarter), a 43% increase in Q3 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 575 $270.00K New
Q3 2024 2.17K $1.01M Add
Q4 2024 6.03K $2.43M Add
Q1 2025 7.95K $3.86M Add
Q2 2025 8.15K $3.63M Add
Q3 2025 7.88K $3.08M Reduce
Q4 2025 9.04K $4.10M Add
Q1 2026 9.14K $4.08M Add
Q2 2026 9.28K $4.61M Add
Q3 2026 13.29K $6.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Peloton Wealth Strategists held VRTX?

Peloton Wealth Strategists has disclosed VRTX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Peloton Wealth Strategists's current position in VRTX?

As of Q3 2026, Peloton Wealth Strategists holds 13.29K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $6.95M, representing 2.54% of its reported portfolio and ranking #11.

Has Peloton Wealth Strategists been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Peloton Wealth Strategists increased its position in VRTX. The position peaked in Q3 2026 at 13.29K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.